多巴胺受体基因多态性与抗躁狂治疗的进展
Dopamine Receptor Gene Polymorphisms and Therapy Advances for Antimanic
DOI: 10.12677/IJPN.2023.123005, PDF,    科研立项经费支持
作者: 陶何健：浙江中医药大学第二临床医学院，浙江 杭州；金卫东, 孙峰俐*：浙江省精神卫生中心浙江省立同德医院精神卫生科，浙江 杭州
关键词: 双相障碍；多巴胺受体；基因位点疗效；Bipolar Disorder； Dopamine Receptor； Gene Locus Therapy Efficacy
摘要: 双相障碍(Bipolar Disorder, BD)是情感高涨与低落相互交替发作的一种精神疾病。BD的相关家系调查和双生子寄养子研究表明，其遗传率高达60%~85%，但其遗传学并不很清楚，也不符合孟德尔遗传定律。国内外均已经展开了一些BD相关基因遗传多态性研究，来寻找攻克这一疾病的突破口。研究较多之一的是多巴胺受体基因，根据BD多巴胺机制的理论假设认为双相躁狂发作与多巴胺功能亢进有关，反之则产生抑郁症状，从而形成循环性的特点。相关文献和研究不多，促使我们进行这方面的研究和探讨。本综述将探讨多巴胺受体基因多态性与抗躁狂治疗进展。
Abstract: Bipolar disorder (BD) is a mental illness that alternates between emotional highs and lows. BD’s related family survey and twin foster study showed that its heritability was as high as 60%~85%, but its genetics was not very clear and did not conform to Gregor Mendel’s genetic law. Both domestically and internationally, some genetic polymorphisms of BD-related genes have been studied to find a breakthrough in overcoming this disease. One of the most studied is the Dopamine receptor gene. According to the theoretical hypothesis of BD dopamine mechanism, it is believed that bipolar manic episode is related to dopamine hyperfunction, and on the contrary, it will produce depressive symptoms, thus forming a cyclical feature. The lack of relevant literature and research has prompted us to conduct research and exploration in this area. This review will explore the Dopa-mine receptor gene polymorphism and the progress of anti-manic treatment.
文章引用：陶何健, 金卫东, 孙峰俐. 多巴胺受体基因多态性与抗躁狂治疗的进展[J]. 国际神经精神科学杂志, 2023, 12(3): 42-48. https://doi.org/10.12677/IJPN.2023.123005

参考文献

[1] Whiteford, H.A., Degenhardt, L., Rehm, J., et al. (2010) Global Burden of Disease Attributable to Mental and Substance Use Disorders: Findings from the Global Burden of Disease Study. The Lancet, 382, 1575-1586. [Google Scholar] [CrossRef] 
[2] Hu, H.R., Hu, C.Y., Ren, Z.H., et al. (2020) Trends in the Incidence and DALYs of Bipolar Disorder at Global, Regional, and National Levels: Results from the Global Burden of Disease Study 2017. Journal of Psychiatric Research, 125, 96-105. [Google Scholar] [CrossRef] [PubMed]
[3] Zutshi, A., Eckert, K.A., Hawthorne, G., et al. (2011) Changes in the Prevalence of Bipolar Disorders between 1998 and 2008 in an Australian Population. Bipolar Disorder, 13, 182-188. [Google Scholar] [CrossRef] [PubMed]
[4] Clemente, A.S., Diniz, B.S., Nicolato, R., et al. (2015) Bi-polar Disorder Prevalence: A Systematic Review and Meta-Analysis of the Literature. Brazilian Journal of Psychiatry, 37, 155-161. [Google Scholar] [CrossRef] [PubMed]
[5] Kessing, L.V., González-Pinto, A., Fagiolini, A., et al. (2021) DSM-5 and ICD-11 Criteria for Bipolar Disorder: Implications for the Prevalence of Bipolar Disorder and Validity of the Diagnosis—A Narrative Review from the ECNP Bipolar Disorders Network. European Neuropsychopharmacology, 47, 54-61. [Google Scholar] [CrossRef] [PubMed]
[6] Mezes, B., Lobban, F., Deborah, C.D., et al. (2022) Recov-ery beyond Clinical Improvement—Recovery Outcomes Measured for People with Bipolar Disorder between 1980 and 2020. Journal of Affective Disorders, 309, 375-392. [Google Scholar] [CrossRef] [PubMed]
[7] Vieta, E., Salagre, E., Grande, I., et al. (2018) Early Intervention in Bipolar Disorder. American Journal of Psychiatry, 175, 411-426. [Google Scholar] [CrossRef] [PubMed]
[8] Carvalho, A.F., Firth, J. and Vieta, E. (2020) Bipolar Disor-der. The New England Journal of Medicine, 383, 58-66. [Google Scholar] [CrossRef] 
[9] Robles, A.I., Yang, P., Jen, J., McClary, A.C., et al. (2014) A DRD1 Polymorphism Predisposes to Lung Cancer among Those Exposed to Secondhand Smoke during Childhood. Cancer Prevention Research (Phila), 7, 1210-1218. [Google Scholar] [CrossRef] 
[10] Kishi, T., Ikuta, T., Matsuda, Y., et al. (2022) Pharmaco-logical Treatment for Bipolar Mania: A Systematic Review and Network Meta-Analysis of Double-Blind Randomized Controlled Trials. Molecular Psychiatry, 27, 1136-1144. [Google Scholar] [CrossRef] [PubMed]
[11] Yao, J., Ding, M., Xing, J., et al. (2014) Genetic Association between the Dopamine D1-Receptor Gene and Paranoid Schizophrenia in a Northern Han Chinese Population. Neuro-psychiatric Disease and Treatment, 10, 645-652. [Google Scholar] [CrossRef] 
[12] Elinsky, G.S., Sirois, C.L., Rich, M.T., et al. (2013) Dopamine Recep-tors in Human Embryonic Stem Cell Neurodifferentiation. Stem Cells and Development, 22, 1522-1540. [Google Scholar] [CrossRef] [PubMed]
[13] Lee, S.H., Kim, Y.M., Yajima, S., et al. (2003) Genomic Organization and Promoter Characterization of the Murine Dopamine Receptor Regulating Factor (DRRF) Gene. Gene, 304, 193-199. [Google Scholar] [CrossRef] 
[14] Kim, O.S., Kim, H.J. and Kwak, H.J. (2003) Human Act and AR1 Sequences Differentially Regulate Murine and Human D1A Dopamine Receptor Promoters. Molecules and Cells, 15, 294-300.
[15] Cipolletta, E., Ciccarelli, M., Izzo, R., et al. (2012) A Polymorphism within the Promoter of the Dopamine Receptor D1 (DRD1-48A/G) Associates with Impaired Kidney Function in White Hypertensive Patients. Translational Medicine @ UniSa, 2, 10-19.
[16] Pan, Y., Yao, J. and Wang, B. (2014) Association of Dopamine D1 Receptor Gene Polymorphism with Schizophrenia: A Meta-Analysis. Neuropsychiatric Disease and Treatment, 10, 1133-1139. [Google Scholar] [CrossRef] 
[17] Dmitrzak-Weglarz, M., Rybakowski, J.K. and Slopien, A. (2006) Dopamine Receptor D1 Gene-48A/G Polymorphism Is Associated with Bipolar Illness but Not with Schizophre-nia in a Polish Population. Neuropsychobiology, 53, 46-50. [Google Scholar] [CrossRef] [PubMed]
[18] Bocchetta, A. and Traccis, F. (2017) The Sardinian Puzzle: Concentration of Major Psychoses and Suicide in the Same Sub-Regions across One Century. Clinical Practice and Epidemiology in Mental Health, 13, 246-254. [Google Scholar] [CrossRef] [PubMed]
[19] Dmitrzak-Weglarz, M., Szczepankiewicz, A., Rybakowski, J., et al. (2021) Expression Biomarkers of Pharmacological Treatment Outcomes in Women with Unipolar and Bipolar De-pression. Pharmacopsychiatry, 54, 261-268. [Google Scholar] [CrossRef] [PubMed]
[20] Zhao, L.S., Lin, Y., Lao, G.H., et al. (2015) Association Study of Dopa-mine Receptor Genes Polymorphism with Cognitive Functions in Bipolar I Disorder Patients. Journal of Affective Disor-ders, 170, 85-90. [Google Scholar] [CrossRef] [PubMed]
[21] Zhang, C., Wu, Z.G., Shao, Y., et al. (2011) Association Analysis between Dopamine D1 Receptor Gene and Symptom Quantitative Trait of Schizophrenia. Chinese Medical Journal, 91, 2019-2022.
[22] Niu, Y.M., Zhang, J. and Tang, H. (2023) Association between DRD2/ANKK1 rs1800497 C > T Polymorphism and Post-Traumatic Stress Disorder Susceptibility: A Multivariate Meta-Analysis. Frontiers in Neurosci-ence, 17, Article ID: 1102573. [Google Scholar] [CrossRef] [PubMed]
[23] Daza-Hernández, S., Pérez-Luque, E. and Martínez-Cordero, C. (2023) Analysis of Factors Associated with Outcomes of Bariatric Surgery: rs1800497 ANKK1, rs1799732 DRD2 Genetic Polymorphisms, Eating Behavior, Hedonic Hunger, and Depressive Symptoms. Journal of Gastrointestinal Surgery. [Google Scholar] [CrossRef] [PubMed]
[24] Qin, Y., Sun, Q. and Wang, L. (2023) DRD2 TaqIA Polymorphism-Related Functional Connectivity between Anterior Insula and Dorsolateral Pre-frontal Cortex Predicts the Retention Time in Heroin-Dependent Individuals under Methadone Maintenance Treatment. European Archives of Psychiatry and Clinical Neuroscience. [Google Scholar] [CrossRef] [PubMed]
[25] Zou, Y.F., Wang, F., Feng, X.L., et al. (2012) Association of DRD2 Gene Polymorphisms with Mood Disorders: A Meta-Analysis. Journal of Affective Disorders, 136, 229-237. [Google Scholar] [CrossRef] [PubMed]
[26] 张明, 张钊, 魏之昀, 等. 多巴胺D2受体基因与精神分裂症和双相情感障碍关联研究的荟萃分析[J]. 国际遗传学杂志, 2010, 33(1): 5-11. [Google Scholar] [CrossRef] 
[27] 张沛文, 邹韶红. 儿童青少年双相障碍冲动攻击行为相关基因研究进展[J]. 国际精神病学杂志, 2020, 47(6): 1099-1101. [Google Scholar] [CrossRef] 
[28] Del Casale, A., Paolini, M., Gentile, G., et al. (2022) Dopa-mine DRD2 and DRD3 Polymorphisms Involvement in Nicotine Dependence in Patients with Treatment-Resistant Men-tal Disorders. Journal of Personalized Medicine, 12, 565. [Google Scholar] [CrossRef] [PubMed]
[29] Peciña, M., Sikora, M. and Avery, E.T. (2017) Striatal Dopamine D2/3 Receptor-Mediated Neurotransmission in Major Depression: Implications for Anhedonia, Anxiety and Treatment Re-sponse. European Neuropsychopharmacology, 27, 977-986. [Google Scholar] [CrossRef] [PubMed]
[30] Park, C.I., Kim, H.W., Hwang, S.S., et al. (2021) Influence of Dopamine-Related Genes on Craving, Impulsivity, and Aggressiveness in Korean Males with Alcohol Use Disorder. European Archives of Psychiatry and Clinical Neuroscience, 271, 865-872. [Google Scholar] [CrossRef] [PubMed]
[31] Chang, T.T., Chen, S.L. and Chang, Y.H. (2016) The DRD3 Ser9Gly Polymorphism Predicted Metabolic Change in Drug-Naive Patients with Bipolar II Disorder. Medicine (Balti-more), 95, e3488. [Google Scholar] [CrossRef] 
[32] 胡伟, 邹韶红, 佟钙玉, 等. 双相情感障碍冲动攻击行为相关基因研究进展[J]. 国际精神病学杂志, 2018, 45(5): 781-784. [Google Scholar] [CrossRef] 
[33] 王燕. DRD4基因rs752306多态性与蒙古族学龄儿童攻击行为的相关性研究[J]. 绿色科技, 2018(1): 220-223.
[34] Nguyen, T.M.L., Jollant, F., Tritschler, L., et al. (2023) Pharmacological Mechanism of Ketamine in Suicidal Behavior Based on Animal Models of Aggressiveness and Impul-sivity: A Narrative Review. Pharmaceuticals (Basel), 16, Article No. 634. [Google Scholar] [CrossRef] [PubMed]
[35] Tunbridge, E.M., Narajos, M. and Harrison, C.H. (2019) Which Dopa-mine Polymorphisms Are Functional? Systematic Review and Meta-Analysis of COMT, DAT, DBH, DDC, DRD1-5, MAOA, MAOB, TH, VMAT1, and VMAT2. Biological Psychiatry, 86, 608-620. [Google Scholar] [CrossRef] [PubMed]
[36] Maingret, F. and Groc, L. (2021) Characterization of the Func-tional Cross-Talk between Surface GABAA and Dopamine D5 Receptors. International Journal of Molecular Sciences, 22, Article No. 4867. [Google Scholar] [CrossRef] [PubMed]
[37] Amare, A.T., Schubert, K.O. and Baune, B.T. (2017) Phar-macogenomics in the Treatment of Mood Disorders: Strategies and Opportunities for Personalized Psychiatry. EPMA Journal, 8, 211-227. [Google Scholar] [CrossRef] [PubMed]
[38] van der Burg, N.C., Al Hadithy, A.F.Y., van Harten, P.N., et al. (2020) The Genetics of Drug-Related Movement Disorders, an Umbrella Review of Meta-Analyses. Molecular Psychia-try, 25, 2237-2250. [Google Scholar] [CrossRef] [PubMed]
[39] Juza, R., Stefkova, K. and Dehaen, W. (2021) Synthesis and in Vitro Evaluation of Novel Dopamine Receptor D2 3,4-Dihydroquinolin-2(1H)-One Derivatives Related to Aripiprazole. Biomolecules, 11, Article No. 1262. [Google Scholar] [CrossRef] [PubMed]
[40] Blacker, C.J., Lewis, C.P. and Frye, M.A. (2017) Metabotropic Glu-tamate Receptors as Emerging Research Targets in Bipolar Disorder. Psychiatry Research, 257, 327-337. [Google Scholar] [CrossRef] [PubMed]